Endocrine therapies in breast cancer /
Saved in:
Imprint: | Oxford ; New York : Oxford University Press, 2007. |
---|---|
Description: | 1 online resource (viii, 120 pages) : illustrations |
Language: | English |
Series: | Oxford oncology library Oxford oncology library. |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11138879 |
MARC
LEADER | 00000cam a2200000Ka 4500 | ||
---|---|---|---|
001 | 11138879 | ||
006 | m o d | ||
007 | cr cnu---unuuu | ||
008 | 120723s2007 enka ob 001 0 eng d | ||
005 | 20240510212901.2 | ||
010 | |z 2007038907 | ||
019 | |a 801363649 |a 961618370 |a 962602314 |a 966212272 |a 988501072 |a 992094670 |a 1037791981 |a 1038614370 |a 1045514218 |a 1055366187 |a 1066545960 |a 1081286810 |a 1153554442 | ||
020 | |a 9780191575174 |q (electronic bk.) | ||
020 | |a 0191575178 |q (electronic bk.) | ||
020 | |z 9780199218141 | ||
020 | |z 0199218145 | ||
035 | |a (OCoLC)801405943 |z (OCoLC)801363649 |z (OCoLC)961618370 |z (OCoLC)962602314 |z (OCoLC)966212272 |z (OCoLC)988501072 |z (OCoLC)992094670 |z (OCoLC)1037791981 |z (OCoLC)1038614370 |z (OCoLC)1045514218 |z (OCoLC)1055366187 |z (OCoLC)1066545960 |z (OCoLC)1081286810 |z (OCoLC)1153554442 | ||
035 | 9 | |a (OCLCCM-CC)801405943 | |
040 | |a N$T |b eng |e pn |c N$T |d E7B |d OCLCQ |d OCLCF |d OCLCQ |d NLGGC |d OCLCO |d YDXCP |d OCLCQ |d EBLCP |d IDEBK |d OCLCO |d OCLCQ |d AZK |d OCLCO |d LOA |d UKOUP |d OCLCA |d COCUF |d TOA |d OCLCO |d AGLDB |d OCLCO |d MOR |d CCO |d PIFAG |d ZCU |d OCLCO |d OCLCQ |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCO |d STF |d OCLCO |d WRM |d VNS |d OCLCO |d VTS |d NRAMU |d ICG |d VT2 |d AU@ |d OCLCO |d OCLCQ |d WYU |d OCLCA |d REC |d OCLCO |d DKC |d OCLCQ |d UX1 |d OCLCQ |d OCLCA |d UKCRE |d UKAHL |d AJS | ||
049 | |a MAIN | ||
050 | 4 | |a RC280.B8 |b E523 2007eb | |
060 | 4 | |a WP 870 |b E56 2007 | |
072 | 7 | |a HEA |x 039030 |2 bisacsh | |
072 | 7 | |a MED |x 062000 |2 bisacsh | |
245 | 0 | 0 | |a Endocrine therapies in breast cancer / |c edited by Aman U. Buzdar. |
260 | |a Oxford ; |a New York : |b Oxford University Press, |c 2007. | ||
300 | |a 1 online resource (viii, 120 pages) : |b illustrations | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
490 | 1 | |a Oxford oncology library | |
504 | |a Includes bibliographical references and index. | ||
505 | 0 | |a Selection of patients for endocrine therapies / W. Fraser Symmans and Lajos Pusztai -- Ovarian ablation / Kellie l. Jones -- Antioestrogens / John F. Forbes -- Aromatase inhibitors in early and advanced disease / Laura Boehnke Michaud -- Fulvestrant in metastatic disease / Amit Agrawal, J.F.R. Robertson, and K.L. Cheung -- Progestins and androgens / Janet l. Espirito -- Combined endocrine and chemotherapy in breast cancer / Ishmael Jaiyesimi [and others] -- Hormone replacement therapy in patients with a prior history of breast cancer / Gilbert G. Fareau and Rena Vassilopoulou-Sellin -- Chemoprevention / Saheenah Dawood and Jack Cuzick. | |
588 | 0 | |a Print version record. | |
520 | |a Breast cancer is one of the leading causes of cancer mortality in women worldwide, and the risk of disease recurrence continues despite improvements in screening and treatment. For patients with hormone receptor-positive breast cancer, some form of endocrine therapy is central to the management of their disease. Tamoxifen has long been the mainstay of endocrine therapy in this group of patients. However, there is mounting evidence showing that the aromatase inhibitors are able toreduce overall oestrogen levels and appear to be better tolerated over a long term than tamoxifen. New and emerging. | ||
650 | 0 | |a Breast |x Cancer |x Hormone therapy. | |
650 | 0 | |a Breast |x Cancer |x Endocrine aspects. | |
650 | 1 | 2 | |a Breast Neoplasms |x drug therapy. |
650 | 2 | 2 | |a Antineoplastic Agents, Hormonal |x therapeutic use. |
650 | 7 | |a HEALTH & FITNESS |x Diseases |x Cancer. |2 bisacsh | |
650 | 7 | |a MEDICAL |x Oncology. |2 bisacsh | |
650 | 7 | |a Breast |x Cancer |x Endocrine aspects. |2 fast |0 (OCoLC)fst00838273 | |
650 | 7 | |a Breast |x Cancer |x Hormone therapy. |2 fast |0 (OCoLC)fst00838281 | |
655 | 0 | |a Electronic books. | |
655 | 4 | |a Electronic books. | |
700 | 1 | |a Buzdar, Aman U. | |
776 | 0 | 8 | |i Print version: |t Endocrine therapies in breast cancer. |d Oxford ; New York : Oxford University Press, 2007 |z 9780199218141 |w (DLC) 2007038907 |w (OCoLC)74966478 |
830 | 0 | |a Oxford oncology library. |0 http://id.loc.gov/authorities/names/n2007184279 | |
903 | |a HeVa | ||
929 | |a oclccm | ||
999 | f | f | |i 7c29eddb-303d-5286-b4b6-5c82eb74db0a |s b02da9e6-f0ae-584b-96d0-041b1b295f13 |
928 | |t Library of Congress classification |a RC280.B8 E523 2007eb |l Online |c UC-FullText |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=467600 |z eBooks on EBSCOhost |g ebooks |i 12372727 |